Europital announces the official launching and availability of its electronic platform PenThu.
Europital announces the official launching and availability of its electronic platform Penthu® for managing medical issues in clinical trials. Penthu® is an innovative and intuitive platform that drives performance, knowledge and efficiencies in clinical trials. This electronic tool allows project teams to provide timely medical guidance and efficiently manage medical issues across multiple projects with minimal effort from the user’s side, thus reducing time, energy and resources while maximizing quality, knowledge and transparency.
Read the full release here.
Tecentriq Falls Short in Phase III Trial in Post-Surgery Triple-Negative Breast Cancer Patients
February 6th 2025In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve treatment outcomes for patients with high-risk early-stage triple-negative breast cancer.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.